298 related articles for article (PubMed ID: 16968899)
1. Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex.
Heemskerk MH; Hagedoorn RS; van der Hoorn MA; van der Veken LT; Hoogeboom M; Kester MG; Willemze R; Falkenburg JH
Blood; 2007 Jan; 109(1):235-43. PubMed ID: 16968899
[TBL] [Abstract][Full Text] [Related]
2. Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region.
Heemskerk MH; Hoogeboom M; de Paus RA; Kester MG; van der Hoorn MA; Goulmy E; Willemze R; Falkenburg JH
Blood; 2003 Nov; 102(10):3530-40. PubMed ID: 12869497
[TBL] [Abstract][Full Text] [Related]
3. Alphabeta T-cell receptor engineered gammadelta T cells mediate effective antileukemic reactivity.
van der Veken LT; Hagedoorn RS; van Loenen MM; Willemze R; Falkenburg JH; Heemskerk MH
Cancer Res; 2006 Mar; 66(6):3331-7. PubMed ID: 16540688
[TBL] [Abstract][Full Text] [Related]
4. Single T cell receptor-mediated recognition of an identical HIV-derived peptide presented by multiple HLA class I molecules.
Ueno T; Tomiyama H; Takiguchi M
J Immunol; 2002 Nov; 169(9):4961-9. PubMed ID: 12391209
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer.
Heemskerk MH; Hoogeboom M; Hagedoorn R; Kester MG; Willemze R; Falkenburg JH
J Exp Med; 2004 Apr; 199(7):885-94. PubMed ID: 15051765
[TBL] [Abstract][Full Text] [Related]
6. Promiscuous behavior of HPV16E6 specific T cell receptor beta chains hampers functional expression in TCR transgenic T cells, which can be restored in part by genetic modification.
Scholten KB; Ruizendaal JJ; Graf M; Schoedl T; Kramer D; Meijer CJ; Man S; Hooijberg E
Cell Oncol; 2010; 32(1-2):43-56. PubMed ID: 20208133
[TBL] [Abstract][Full Text] [Related]
7. Dual recognition of a human cytotoxic T-cell clone for melanoma antigens.
Kubo H; Abe J; Obata F; Nakajima H; Tsunoda M; Ogawa A; Nakayama S; Beck Y; Kohsaka T; Darrow TL; Abdel-Wahab Z; Saida T; Takiguchi M
Cancer Res; 1996 May; 56(10):2368-74. PubMed ID: 8625313
[TBL] [Abstract][Full Text] [Related]
8. Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR.
Okamoto S; Mineno J; Ikeda H; Fujiwara H; Yasukawa M; Shiku H; Kato I
Cancer Res; 2009 Dec; 69(23):9003-11. PubMed ID: 19903853
[TBL] [Abstract][Full Text] [Related]
9. RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma.
Harrer DC; Simon B; Fujii SI; Shimizu K; Uslu U; Schuler G; Gerer KF; Hoyer S; Dörrie J; Schaft N
BMC Cancer; 2017 Aug; 17(1):551. PubMed ID: 28818060
[TBL] [Abstract][Full Text] [Related]
10. Rapid re-expression of retrovirally introduced versus endogenous TCRs in engineered T cells after antigen-specific stimulation.
van Loenen MM; Hagedoorn RS; de Boer R; van Egmond EH; Falkenburg JH; Heemskerk MH
J Immunother; 2011 Mar; 34(2):165-74. PubMed ID: 21304404
[TBL] [Abstract][Full Text] [Related]
11. Use of the V delta 1 variable region in the functional T-cell receptor alpha chain of a WT31+ cytotoxic T lymphocyte clone which specifically recognizes HLA-A2 molecule.
Castelli C; Mazzocchi A; Salvi S; Anichini A; Sensi M
Scand J Immunol; 1992 Apr; 35(4):487-94. PubMed ID: 1313600
[TBL] [Abstract][Full Text] [Related]
12. Functional comparison of engineered T cells carrying a native TCR versus TCR-like antibody-based chimeric antigen receptors indicates affinity/avidity thresholds.
Oren R; Hod-Marco M; Haus-Cohen M; Thomas S; Blat D; Duvshani N; Denkberg G; Elbaz Y; Benchetrit F; Eshhar Z; Stauss H; Reiter Y
J Immunol; 2014 Dec; 193(11):5733-43. PubMed ID: 25362181
[TBL] [Abstract][Full Text] [Related]
13. Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide.
Moss PA; Moots RJ; Rosenberg WM; Rowland-Jones SJ; Bodmer HC; McMichael AJ; Bell JI
Proc Natl Acad Sci U S A; 1991 Oct; 88(20):8987-90. PubMed ID: 1833769
[TBL] [Abstract][Full Text] [Related]
14. Extensive T cell receptor cross-reactivity on structurally diverse haptenated peptides presented by HLA-A2.
Gagnon SJ; Turner RV; Shiue MG; Damirjian M; Biddison WE
Mol Immunol; 2006 Feb; 43(4):346-56. PubMed ID: 16310048
[TBL] [Abstract][Full Text] [Related]
15. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
Duong MN; Erdes E; Hebeisen M; Rufer N
J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
[TBL] [Abstract][Full Text] [Related]
16. TCR reconstitution in Jurkat reporter cells facilitates the identification of novel tumor antigens by cDNA expression cloning.
Aarnoudse CA; Krüse M; Konopitzky R; Brouwenstijn N; Schrier PI
Int J Cancer; 2002 May; 99(1):7-13. PubMed ID: 11948485
[TBL] [Abstract][Full Text] [Related]
17. Exploitation of CD3ζ to enhance TCR expression levels and antigen-specific T cell function.
Degirmencay A; Thomas S; Holler A; Burgess S; Morris EC; Stauss HJ
Front Immunol; 2024; 15():1386132. PubMed ID: 38873603
[TBL] [Abstract][Full Text] [Related]
18. Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes.
Engels B; Noessner E; Frankenberger B; Blankenstein T; Schendel DJ; Uckert W
Hum Gene Ther; 2005 Jul; 16(7):799-810. PubMed ID: 16000062
[TBL] [Abstract][Full Text] [Related]
19. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
[TBL] [Abstract][Full Text] [Related]
20. Peptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCR alpha beta genes into primary human T lymphocytes.
Schaft N; Willemsen RA; de Vries J; Lankiewicz B; Essers BW; Gratama JW; Figdor CG; Bolhuis RL; Debets R; Adema GJ
J Immunol; 2003 Feb; 170(4):2186-94. PubMed ID: 12574392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
